Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study.

Rodríguez-Reyna TS, Furuzawa-Carballeda J, Cabiedes J, Fajardo-Hermosillo LD, Martínez-Reyes C, Díaz-Zamudio M, Llorente L.

Rheumatol Int. 2012 Sep;32(9):2653-60. doi: 10.1007/s00296-011-2056-y. Epub 2011 Jul 26.

PMID:
21789610
2.

Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients.

Krasimirova E, Velikova T, Ivanova-Todorova E, Tumangelova-Yuzeir K, Kalinova D, Boyadzhieva V, Stoilov N, Yoneva T, Rashkov R, Kyurkchiev D.

World J Exp Med. 2017 Aug 20;7(3):84-96. doi: 10.5493/wjem.v7.i3.84. eCollection 2017 Aug 20.

3.

Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.

Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA.

Cytokine. 2015 Apr;72(2):146-53. doi: 10.1016/j.cyto.2014.12.027. Epub 2015 Jan 31.

PMID:
25647269
4.

Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus.

Dolff S, Bijl M, Huitema MG, Limburg PC, Kallenberg CG, Abdulahad WH.

Clin Immunol. 2011 Nov;141(2):197-204. doi: 10.1016/j.clim.2011.08.005. Epub 2011 Aug 16.

PMID:
21920821
5.
6.

Peripheral blood Th17/Treg imbalance in patients with low-active systemic lupus erythematosus.

Szmyrka-Kaczmarek M, Kosmaczewska A, Ciszak L, Szteblich A, Wiland P.

Postepy Hig Med Dosw (Online). 2014;68:893-8.

7.

Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study.

Furuzawa-Carballeda J, Lima G, Jakez-Ocampo J, Llorente L.

Eur J Clin Invest. 2011 Oct;41(10):1037-46. doi: 10.1111/j.1365-2362.2011.02491.x. Epub 2011 Mar 2.

PMID:
21366559
8.

T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.

Almeida I, Silva SV, Fonseca AR, Silva I, Vasconcelos C, Lima M.

Clin Rev Allergy Immunol. 2015 Dec;49(3):347-69. doi: 10.1007/s12016-015-8505-8. Review.

PMID:
26445774
9.

Increased serum soluble CD40 levels in patients with systemic sclerosis.

Komura K, Fujimoto M, Matsushita T, Yanaba K, Kodera M, Kawasuji A, Hasegawa M, Takehara K, Sato S.

J Rheumatol. 2007 Feb;34(2):353-8. Epub 2007 Jan 15.

PMID:
17295440
10.

Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.

Truchetet ME, Brembilla NC, Montanari E, Allanore Y, Chizzolini C.

Arthritis Res Ther. 2011;13(5):R166. doi: 10.1186/ar3486. Epub 2011 Oct 13.

11.

A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.

Mondini M, Vidali M, De Andrea M, Azzimonti B, Airò P, D'Ambrosio R, Riboldi P, Meroni PL, Albano E, Shoenfeld Y, Gariglio M, Landolfo S.

Arthritis Rheum. 2006 Dec;54(12):3939-44.

12.

Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.

Zhen Y, Yao L, Zhong S, Song Y, Cui Y, Li S.

Arch Dermatol Res. 2016 Dec;308(10):703-710. Epub 2016 Sep 29.

PMID:
27687555
13.

Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis.

Wagner A, Köhm M, Nordin A, Svenungsson E, Pfeilschifter JM, Radeke HH.

Scand J Immunol. 2015 Sep;82(3):269-74. doi: 10.1111/sji.12317.

14.

Imbalance of Th17 to Th1 cells in Behçet's disease.

Kim J, Park JA, Lee EY, Lee YJ, Song YW, Lee EB.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S16-9. Epub 2010 Sep 23.

PMID:
20868565
15.

Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score.

Dziadzio M, Smith RE, Abraham DJ, Black CM, Denton CP.

Rheumatology (Oxford). 2005 Dec;44(12):1518-24. Epub 2005 Sep 13.

PMID:
16159952
16.

CD4+ T helper cells and regulatory T cells in active lupus nephritis: an imbalance towards a predominant Th1 response?

Mesquita D Jr, Kirsztajn GM, Franco MF, Reis LA, Perazzio SF, Mesquita FV, Ferreira VDS, Andrade LEC, de Souza AWS.

Clin Exp Immunol. 2018 Jan;191(1):50-59. doi: 10.1111/cei.13050. Epub 2017 Oct 10.

PMID:
28945272
17.

Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis.

Almanzar G, Klein M, Schmalzing M, Hilligardt D, El Hajj N, Kneitz H, Wild V, Rosenwald A, Benoit S, Hamm H, Tony HP, Haaf T, Goebeler M, Prelog M.

Int Arch Allergy Immunol. 2016;171(2):141-154. doi: 10.1159/000450949. Epub 2016 Dec 1.

18.

Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study.

Baraut J, Grigore EI, Jean-Louis F, Khelifa SH, Durand C, Verrecchia F, Farge D, Michel L.

Bone Marrow Transplant. 2014 Mar;49(3):349-54. doi: 10.1038/bmt.2013.202. Epub 2013 Dec 23.

PMID:
24362364
19.

Circulating T helper and T regulatory subsets in untreated early rheumatoid arthritis and healthy control subjects.

Pandya JM, Lundell AC, Hallström M, Andersson K, Nordström I, Rudin A.

J Leukoc Biol. 2016 Oct;100(4):823-833. Epub 2016 May 17.

PMID:
27190305
20.

A study on relationship among apoptosis rates, number of peripheral T cell subtypes and disease activity in rheumatoid arthritis.

Ji L, Geng Y, Zhou W, Zhang Z.

Int J Rheum Dis. 2016 Feb;19(2):167-71. doi: 10.1111/1756-185X.12211. Epub 2013 Oct 31.

PMID:
24618356

Supplemental Content

Support Center